State Street Corp Grows Stock Holdings in Teleflex Incorporated (NYSE:TFX)

State Street Corp increased its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 1.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,057,080 shares of the medical technology company's stock after purchasing an additional 21,291 shares during the quarter. State Street Corp owned 4.43% of Teleflex worth $508,757,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of TFX. CWM LLC grew its stake in shares of Teleflex by 22.9% in the second quarter. CWM LLC now owns 1,317 shares of the medical technology company's stock valued at $277,000 after buying an additional 245 shares in the last quarter. SG Americas Securities LLC grew its stake in shares of Teleflex by 99.3% in the second quarter. SG Americas Securities LLC now owns 13,791 shares of the medical technology company's stock worth $2,901,000 after acquiring an additional 6,871 shares in the last quarter. Czech National Bank raised its holdings in Teleflex by 8.6% in the second quarter. Czech National Bank now owns 8,975 shares of the medical technology company's stock valued at $1,888,000 after acquiring an additional 708 shares in the last quarter. Sequoia Financial Advisors LLC lifted its holdings in Teleflex by 3.9% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 6,484 shares of the medical technology company's stock worth $1,364,000 after buying an additional 246 shares during the last quarter. Finally, Hengehold Capital Management LLC acquired a new position in shares of Teleflex in the 2nd quarter valued at $216,000. Hedge funds and other institutional investors own 95.62% of the company's stock.

Teleflex Stock Up 1.3 %

Shares of TFX traded up $2.43 on Monday, reaching $187.08. The company's stock had a trading volume of 397,328 shares, compared to its average volume of 383,727. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The firm has a fifty day moving average of $214.17 and a 200-day moving average of $221.47. Teleflex Incorporated has a twelve month low of $184.19 and a twelve month high of $257.85. The stock has a market capitalization of $8.69 billion, a PE ratio of 36.71, a PEG ratio of 1.89 and a beta of 1.16.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.38 by $0.11. The company had revenue of $764.40 million during the quarter, compared to analyst estimates of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm's quarterly revenue was up 2.4% compared to the same quarter last year. During the same period in the previous year, the business earned $3.64 earnings per share. Equities analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be issued a dividend of $0.34 per share. The ex-dividend date is Friday, November 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.73%. Teleflex's payout ratio is 27.04%.

Analyst Ratings Changes

A number of equities analysts recently issued reports on TFX shares. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a report on Friday, November 1st. Royal Bank of Canada decreased their price objective on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. Truist Financial reaffirmed a "hold" rating and set a $227.00 price objective (down previously from $255.00) on shares of Teleflex in a research note on Monday, November 4th. Mizuho reduced their target price on Teleflex from $275.00 to $250.00 and set a "neutral" rating on the stock in a research report on Friday, November 1st. Finally, StockNews.com raised Teleflex from a "hold" rating to a "buy" rating in a research report on Thursday, November 28th. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, Teleflex has an average rating of "Moderate Buy" and an average price target of $259.00.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.